Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

Published:2021-03-25 Issue:8 Volume:56 Page:1919-1928
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bento Leyre^ORCID,Gutiérrez Antonio,Novelli Silvana^ORCID,Montoro Juan^ORCID,Piñana J. L.^ORCID,López-Corral Lucía,Cabrero Mónica,Martín-Sancho Alejandro^ORCID,Gutiérrez-García Gonzalo^ORCID,Ortiz-Moscovich Marcela,Bastos-Oreiro Mariana^ORCID,Dorado Nieves,Pérez Ariadna,Hernani Rafael^ORCID,Ferrà Christelle^ORCID,Parody Rocío,García-Cadenas Irene^ORCID,Herrera Pilar,Rodríguez Guillermo,Rodríguez Nancy,Martín Carmen,Yáñez Lucrecia,Zanabili Joud^ORCID,Varela María Rosario^ORCID,López-Godino Oriana,Heras Inmaculada,Español Ignacio,Martínez Carmen^ORCID,Pérez-Simón José Antonio,Solano Carlos^ORCID,Sureda Anna,Sierra Jordi^ORCID,Sampol Antonia,Caballero Dolores,

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01264-3.pdf

Reference35 articles.

1. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med. 1995;333:1540–5.

2. Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130:1800–8.

3. van Kampen RJW, Canals C, Schouten HC, Nagler A, Thomson KJ, Vernant J-P, et al. Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin’s lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. J Clin Oncol. 2011;29:1342–8.

4. Bacher U, Klyuchnikov E, Le-Rademacher J, Carreras J, Armand P, Bishop MR, et al. Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? Blood. 2012;120:4256–62.

5. Fenske TS, Ahn KW, Graff TM, DiGilio A, Bashir Q, Kamble RT, et al. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. Br J Haematol. 2016;174:235–48.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years;Blood Cancer Journal;2024-07-05

2. EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-07-03

3. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature;Annals of Hematology;2024-03-02

4. Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era;BMC Cancer;2024-01-13

5. Large B-Cell Lymphoma;The EBMT Handbook;2024